ORAM
MRNA icon

One River Asset Management’s Moderna MRNA Stock Holding History

One River Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$284K – 80
2025
Q1 		$284K Buy
+10,000
New +$355K 0.04% 74
2024
Q4 		– Sell
-2,100
Closed -$140K – 305
2024
Q3 		$140K Buy
2,100
+400
+24% +$36.7K 0.02% 245
2024
Q2 		$202K Buy
+1,700
New +$215K 0.01% 191
2024
Q1 		– Sell
-2,800
Closed -$278K – 298
2023
Q4 		$278K Hold
2,800
– – 0.01% 237
2023
Q3 		$289K Hold
2,800
– – 0.01% 267
2023
Q2 		$340K Sell
2,800
-7,900
-74% -$1.05M 0.04% 194
2023
Q1 		$1.64M Buy
10,700
+10,500
+5,250% +$1.73M 0.07% 162
2022
Q4 		$35.9K Buy
+200
New +$32.7K ﹤0.01% 354

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

One River Asset Management's MRNA Position: Q4 2024 in Review

One River Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 801 shares — an estimated $52.7K sold.

One River Asset Management first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $582K in Q2 2023. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • One River Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • One River Asset Management sold 801 Moderna shares in Q4 2024, an estimated $52.7K.
  • One River Asset Management first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
  • One River Asset Management's Moderna position peaked at $582K in Q2 2023.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on One River Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.